Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 18+ key pharma and biotech companies are working on 20+ pipeline drugs in the Intrahepatic Cholangiocarcinoma therapeutics landscape based on different Routes of Administration (RoA), Mechanism of Action (MoA), and molecule types. Several of the therapies are in the advanced stages of clinical development and […]
